Bone marrow transplantation into Abcd1‐deficient mice: Distribution of donor derived‐cells and biological characterization of the brain of the recipient mice
Bone marrow transplantation into Abcd1‐deficient mice: Distribution of donor derived‐cells and biological characterization of the brain of the recipient mice
复制标题
骨髓移植到 Abcd1 缺陷小鼠中:供体来源细胞的分布和受体小鼠大脑的生物学特征
DOI:
10.1002/jimd.12346
复制
发表时间:
2021
影响因子:
4.2
通讯作者:
Imanaka Tsuneo
中科院分区:
文献类型:
--
作者:
Morita Masashi;Kaizawa Taro;Yoda Taiki;Oyama Takuro;Asakura Reina;Matsumoto Shun;Nagai Yoshinori;Watanabe Yasuharu;Watanabe Shiro;Kobayashi Hiroshi;Kawaguchi Kosuke;Yamamoto Seiji;Shimozawa Nobuyuki;So Takanori;Imanaka Tsuneo
X‐linked adrenoleukodystrophy (X‐ALD) is a severe inherited metabolic disease with cerebral inflammatory demyelination and abnormal accumulation of very long chain fatty acid (VLCFA) in tissues, especially the brain. At present, bone marrow transplantation (BMT) at an early stage of the disease is the only effective treatment for halting disease progression, but the underlying mechanism of the treatment has remained unclear. Here, we transplanted GFP‐expressing wild‐type (WT) orAbcd1‐deficient (KO) bone marrow cells into recipient KO mice, which enabled tracking of the donor GFP+cells in the recipient mice. Both the WT and KO donor cells were equally distributed throughout the brain parenchyma, and displayed an Iba1‐positive, GFAP‐ and Olig2‐negative phenotype, indicating that most of the donor cells were engrafted as microglia‐like cells. They constituted approximately 40% of the Iba1‐positive cells. Unexpectedly, no decrease of VLCFA in the cerebrum was observed when WT bone marrow cells were transplanted into KO mice. Taken together, murine study suggests that bone marrow‐derived microglia‐like cells engrafted in the cerebrum of X‐ALD patients suppress disease progression without evidently reducing the amount of VLCFA in the cerebrum.